Concepedia

Karin S. Ku

KS

8

Publications

527

Citations

8

H-Index

2004

Active since

Affiliations

Gilead Sciences (United States)(Current)

Karin S. Ku is an author at Gilead Sciences (United States) specializing in viral hepatitis, hepatology, and virology.

Top concepts

Publications per year

2004–2023

8

Publications

8

Infrequent Development of Resistance in Genotype 1–6 Hepatitis C Virus–Infected Subjects Treated With Sofosbuvir in Phase 2 and 3 Clinical Trials

Evguenia S. Svarovskaia, Hadas Dvory‐Sobol, Neil Parkin et al. · Clinical Infectious Diseases · 2014 · 213 citations · Full text

Pirtobrutinib preclinical characterization: a highly selective, non-covalent (reversible) BTK inhibitor

Eliana B Gómez, Kevin Ebata, Hetal S Randeria et al. · Blood · 2023 · 84 citations · Full text

Susceptibility of Treatment-Naive Hepatitis C Virus (HCV) Clinical Isolates to HCV Protease Inhibitors

Andrew Bae, Siu-Chi Chang Sun, Xiaoping Qi et al. · Antimicrobial Agents and Chemotherapy · 2010 · 76 citations

, , +14

Differential Detection of Five Mouse-Infecting Helicobacter Species by Multiplex PCR

Sunlian Feng, Karin S. Ku, Emir Hodzic et al. · Clinical and Vaccine Immunology · 2005 · 42 citations · Full text

Inhibition of Hepatitis C Virus Replication by GS-6620, a Potent <i>C</i> -Nucleoside Monophosphate Prodrug

Joy Y. Feng, Guofeng Cheng, Jason K. Perry et al. · Antimicrobial Agents and Chemotherapy · 2014 · 41 citations · Full text

Rows per page

1–5 of 8